BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 17576400)

  • 1. [Evaluation of the hematochemical parameters and bone mineral density of women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and surgical menopause treated with estrogen replacement. Part II].
    Savoca S; D'Agosta S; Lombardo G
    Minerva Ginecol; 2007 Jun; 59(3):215-22. PubMed ID: 17576400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
    Savoca S; D'Agosta S; Lombardo G
    Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nomegestrol acetate may enhance the skeletal effects of estradiol on biochemical markers of bone turnover in menopausal women after a 12-week treatment period.
    Nguyên-Pascal ML; Thomas JL; Bergougnoux L; Garnero P; Drapier-Faure E; Delmas PD
    Climacteric; 2005 Jun; 8(2):136-45. PubMed ID: 16096169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Absence of antiosteopenic effect of hormone replacement therapy in postmenopausal women].
    Ortiz Núñez DA; Mengchún López G; Hernández Marín I; Mendoza R; Ayala Ruíz AR
    Ginecol Obstet Mex; 2004 Jul; 72():349-55. PubMed ID: 15469174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum follicle-stimulating hormone level is a predictor of bone mineral density in patients with hormone replacement therapy.
    Kawai H; Furuhashi M; Suganuma N
    Arch Gynecol Obstet; 2004 Mar; 269(3):192-5. PubMed ID: 13680264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oxidative metabolism of estrogen modulates response to ERT/HRT in postmenopausal women.
    Armamento-Villareal RC; Napoli N; Klug T; Civitelli R
    Bone; 2004 Sep; 35(3):682-8. PubMed ID: 15336604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing changes in bone mineral density in patients with anorexia nervosa-related osteoporosis: the effect of hormone replacement therapy.
    Legroux-Gerot I; Vignau J; Collier F; Cortet B
    Calcif Tissue Int; 2008 Nov; 83(5):315-23. PubMed ID: 18836675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.
    Gambacciani M; Cappagli B; Ciaponi M; Pepe A; Vacca F; Genazzani AR
    Maturitas; 2008 Jan; 59(1):2-6. PubMed ID: 18063490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of nomegestrol acetate on the improvement of the quality of life induced by estrogen therapy in menopausal women].
    Reginster JY; Zartarian M; Colau JC
    Contracept Fertil Sex; 1996 Nov; 24(11):847-51. PubMed ID: 8991589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oestrogen replacement therapy on bone mass in post-menopausal Bangladeshi women.
    Begum F; Shamsuddin L; Hussain MA; Chowdhury TA; Rahman M; Das TR
    Bangladesh Med Res Counc Bull; 2001 Dec; 27(3):103-11. PubMed ID: 12197624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of postmenopausal bone loss with long-cycle hormone replacement therapy.
    Popp AW; Bodmer C; Senn C; Fuchs G; Kraenzlin ME; Wyss H; Birkhaeuser MH; Lippuner K
    Maturitas; 2006 Jan; 53(2):191-200. PubMed ID: 16368472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis.
    Dane C; Dane B; Cetin A; Erginbas M
    Gynecol Endocrinol; 2007 Jul; 23(7):398-403. PubMed ID: 17701771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate and delayed add-back hormonal replacement therapy during ultra long GnRH agonist treatment of chronic cyclical pelvic pain.
    Al-Azemi M; Jones G; Sirkeci F; Walters S; Houdmont M; Ledger W
    BJOG; 2009 Nov; 116(12):1646-56. PubMed ID: 19735378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of menopause on lipid and bone metabolism and effect of hormone replacement therapy.
    Murano T; Izumi S; Kika G; Haque SF; Okuwaki S; Mori A; Suzuki T; Matsubayashi H; Ikeda M; Goya K; Makino T
    Tokai J Exp Clin Med; 2003 Oct; 28(3):109-19. PubMed ID: 15055403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open-label study of subdermal implants of estradiol-only versus subdermal implants of estradiol plus nomegestrol acetate: effects on symptom control, lipid profile and tolerability.
    Barbosa IC; Coutinho EM; Oladapo L; Noronha CF; Mota RL; Lopes AC; Lopes RC
    Gynecol Endocrinol; 2009 Apr; 25(4):269-75. PubMed ID: 19408176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal evaluation of serum leptin and bone mineral density in early postmenopausal women.
    Di Carlo C; Tommaselli GA; Di Spiezio Sardo A; Sammartino A; Attianese W; Gargano V; Bifulco G; Nappi C
    Menopause; 2007; 14(3 Pt 1):450-4. PubMed ID: 17242633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of surgical menopause and Paget's disease of bone on the isomerization of type I collagen carboxyterminal telopeptide: evolution after antiresorptive therapy.
    Peris P; Alvarez L; Monegal A; Guañabens N; Durán M; Echevarría M; Ros I; Ballesta AM; Muñoz-Gómez J
    J Bone Miner Metab; 2002; 20(2):116-20. PubMed ID: 11862534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sr and Fe relationship with hormone replacement therapy and bone mineral density.
    Unfer TC; Müller EI; de Moraes Flores EM; Dressler VL; da Silva JC; Duarte MM; Emanuelli T
    Clin Chim Acta; 2007 Sep; 384(1-2):113-7. PubMed ID: 17618614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of different hormone replacement therapy regimens on tear function, intraocular pressure and lens opacity.
    Uncu G; Avci R; Uncu Y; Kaymaz C; Develioğlu O
    Gynecol Endocrinol; 2006 Sep; 22(9):501-5. PubMed ID: 17071534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.